Clinical Trials Browser

Phase 2 × Multiple Myeloma × Drug Tolerance × Clear all

NCT00807599 2019-03-15

Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L

Phase 2 Completed

67 enrolled 12 charts

Multiple Myeloma